JAKARTA - Breast cancer therapy innovation has come a long way. In the latest development, a breast cancer therapy known as nanocargo is predicted to destroy tumors in the body. The technology that won the EU's highest innovation radar award is currently being developed in Wroclaw, Poland.
Launching Euronews, Thursday, November 26, the advantage of this nanocargo technology lies in the injection of nano particles directly into the tumor. Chief scientist from Wroclaw University of Science and Technology, Joanna Bauer revealed that nanocargo is very powerful and effective in removing tumors from the body.
"We see cancer cells here. The cells that are green are the cells we want to kill. They are all alive for now. You can see here after that. 20 minutes the fewer living cells we want to kill. And finally, after 30 minutes. , with the application of nanoparticles, we have no living cells at all, "he said.
Today I'm filming a story in Wrocław about the Nanocargo project to beat cancer using nanoparticles and lasers for @euronews Futuris series. Breakthrough science, could revolutionize cancer therapy. pic.twitter.com/bgk4ba6lKA
- Jeremy Wilks (@WilksJeremy) October 26, 2020
Bauer added, the experiment with bottles containing thousands of nanoparticles allows researchers to determine the effects of new breast cancer therapies. Because, in the body, the nanoparticles will be heated with lasers and magnetic fields. Because the heat is what will kill cancer cells. After that, chemotherapy drugs will be released from the nano particles right inside the tumor.
"So we have a core that is magnetic and reacts with a magnetic field. On the outside there is an additional metal sheath that is excited by a laser. In addition, we also put in a special drug, which is used during normal breast cancer chemotherapy," Bauer explained.
Nanocargo was welcomedOncologist Rafal Matkowsku, who often uses chemotherapy, radiotherapy, and hormone therapy to treat breast cancer, said he was happy with the presence of nanocargo. Rafal said, Nanocargo can be another option for breast cancer therapy.
"Of course I think doctors still have work to do, because until now there is no cure, no substance, no method that is 100% effective," he said.
Breast cancer survivor Agata Gwadera-Urlep also expressed good reception. She revealed that any innovation is a form of encouragement for breast cancer survivors, even if the treatment is not yet available.
"The realization that there may be something new helps treatment because this mental attitude is very important during illness. It's encouraging," he said.
Get an awardPreviously, nanocargo was created in collaboration with the University of Science and Technology Wroclaw with an Indian scientist Nanaseheb Thorat. For the research, scientists were awarded the European Union Radar Innovation Award, because it is thought to fundamentally change cancer therapy.
“The existing cancer therapy is not targeted, the drugs are everywhere in the body. Our approach is very specific, targeted, and only targets the tumor, not other parts of the body, ”explains Thorat.
"The Radar Innovation Award gives me a great opportunity and a proud moment to transfer my basic knowledge, or ideas, into real-world technology," he added.
Our Nanocargo MSCA project leading the way of breast cancer therapy https://t.co/a1gbdLlULj https://t.co/I4ECt9rjVg
- Nanaso Thorat (thoratnd) May 29, 2020
Meanwhile, Bauer revealed that the nanocargo innovation is expected to be a promising new therapeutic option. Therefore, nanocargo will continue to be researched until a series of clinical trial stages can be carried out.
"We are very pleased with the high appreciation for our work, but above all we are happy that the technology we have developed can help women in the future. This is the most important for us," he concluded.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
